Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)

The Pediatric Oncology Group (POG) phase 3 trial 9404 was designed to determine the effectiveness of high-dose methotrexate (HDM) when added to multi-agent chemotherapy based on the Dana-Farber backbone. Children with T-cell acute lymphoblastic leukemia (T-ALL) or advanced lymphoblastic lymphoma (T-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Asselin, Barbara L., Devidas, Meenakshi, Wang, Chenguang, Pullen, Jeanette, Borowitz, Michael J., Hutchison, Robert, Lipshultz, Steven E., Camitta, Bruce M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2011
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3292437/
https://ncbi.nlm.nih.gov/pubmed/21474675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-06-292615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados